Managed Access Services

EarlyHealth Group supports manufacturers, governments, and patients in accessing treatments not yet registered in certain territories.

In some countries it takes years before the right conditions are met for medicines to be registered, however thousands of patients still have urgent need to access these therapies. EarlyHealth Group has been helping patients and doctors by supplying vital treatments in remote areas for over a decade.

In other situations, Investigational New Drugs (INDs) showing promising results in clinical trials can be made available for patients before obtaining regulatory approval. We are experienced in helping pharmaceutical companies providing early access to treatment for patients in need.